speb/financial-data huggingface dataset:
GERN income_statement (annual, 2023-12-31) — Operating Income: -193944000.00
GERN income_statement (annual, 2023-12-31) — Operating Revenue: 237000.00
GERN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 544912215.00
GERN balance_sheet (annual, 2023-12-31) — Other Current Assets: 4879000.00
GERN balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 46893000.00
GERN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 185000.00
GERN income_statement (annual, 2023-12-31) — Other Gand A: 69135000.00
GERN income_statement (annual, 2023-12-31) — Other Income Expense: -23000.00
GERN cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1088000.00
GERN balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 4697000.00
GERN income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -23000.00
GERN balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 263676000.00
GERN balance_sheet (annual, 2023-12-31) — Payables: 6161000.00
GERN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 46469000.00
GERN cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: 0.00
GERN balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 13759000.00
GERN balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
GERN income_statement (annual, 2023-12-31) — Pretax Income: -184127000.00
GERN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 118984000.00
GERN balance_sheet (annual, 2023-12-31) — Properties: 0.00
GERN cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 0.00
GERN cash_flow (annual, 2023-12-31) — Purchase Of Investment: -475594000.00
GERN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -830000.00
GERN balance_sheet (annual, 2023-12-31) — Receivables: 1655000.00
GERN income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 0.00
GERN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1033000.00
GERN cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
GERN income_statement (annual, 2023-12-31) — Research And Development: 125046000.00
GERN balance_sheet (annual, 2023-12-31) — Restricted Cash: 1115000.00
GERN income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
GERN balance_sheet (annual, 2023-12-31) — Retained Earnings: -1597769000.00
GERN cash_flow (annual, 2023-12-31) — Sale Of Investment: 296102000.00
GERN income_statement (annual, 2023-12-31) — Selling General And Administration: 69135000.00
GERN balance_sheet (annual, 2023-12-31) — Share Issued: 544912215.00
GERN income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
GERN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 19354000.00
GERN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 247949000.00
GERN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 247949000.00
GERN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
GERN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
GERN balance_sheet (annual, 2023-12-31) — Total Assets: 394076000.00
GERN balance_sheet (annual, 2023-12-31) — Total Capitalization: 283000000.00
GERN balance_sheet (annual, 2023-12-31) — Total Debt: 85899000.00
GERN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 247949000.00
GERN income_statement (annual, 2023-12-31) — Total Expenses: 194181000.00
GERN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 146127000.00
GERN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 52728000.00
GERN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 38057000.00
GERN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -193944000.00
GERN income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
GERN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
GERN balance_sheet (annual, 2023-12-31) — Working Capital: 233278000.00
GERN balance_sheet (quarterly, 2024-09-30) — Current Debt: 71562000.00
GERN income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 35877000.00
GERN balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 71562000.00
GERN income_statement (quarterly, 2024-09-30) — Other Gand A: 35877000.00
GERN balance_sheet (quarterly, 2024-09-30) — Other Properties: 4650000.00
GERN cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: 0.00
GERN income_statement (annual, 2024-12-31) — +Operating Expense: 249470000.00
GERN income_statement (annual, 2024-12-31) — +Total Revenue: 76994000.00
GERN balance_sheet (annual, 2024-12-31) — Accounts Payable: 8595000.00
GERN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 35946000.00
GERN balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 2853000.00
GERN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1697000.00
GERN balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1697000.00
GERN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 2051794000.00
GERN cash_flow (annual, 2024-12-31) — Amortization Of Securities: -9683000.00
GERN balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 94519000.00
GERN balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 94519000.00
GERN income_statement (annual, 2024-12-31) — Basic Average Shares: 646033247.00
GERN income_statement (annual, 2024-12-31) — Basic EPS: -0.27
GERN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 71138000.00
GERN balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 2881000.00
GERN balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 2881000.00
GERN cash_flow (annual, 2024-12-31) — Capital Expenditure: -680000.00
GERN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 3240000.00
GERN balance_sheet (annual, 2024-12-31) — Capital Stock: 606000.00
GERN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 79016000.00
GERN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 406566000.00
GERN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 334372000.00
GERN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -106004000.00
GERN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -218618000.00
GERN cash_flow (annual, 2024-12-31) — Change In Account Payable: 2435000.00
GERN cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -4759000.00
GERN cash_flow (annual, 2024-12-31) — Change In Inventory: -37971000.00
GERN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -2901000.00
GERN cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 9049000.00
GERN cash_flow (annual, 2024-12-31) — Change In Payable: 2435000.00
GERN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -2324000.00
GERN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 443000.00
GERN cash_flow (annual, 2024-12-31) — Change In Receivables: -36893000.00
GERN cash_flow (annual, 2024-12-31) — Change In Working Capital: -70597000.00
GERN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -35695000.00
GERN cash_flow (annual, 2024-12-31) — Changes In Cash: 9750000.00
GERN balance_sheet (annual, 2024-12-31) — Common Stock: 606000.00
GERN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 280320000.00
GERN cash_flow (annual, 2024-12-31) — Common Stock Issuance: 140729000.00
GERN cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
GERN income_statement (annual, 2024-12-31) — Cost Of Revenue: 1256000.00
GERN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 34511000.00
GERN balance_sheet (annual, 2024-12-31) — Current Assets: 490992000.00
GERN balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 974000.00
GERN balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 974000.00
GERN balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 1038000.00
GERN balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 1038000.00
GERN balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 1038000.00
GERN balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 1038000.00
GERN balance_sheet (annual, 2024-12-31) — Current Liabilities: 88298000.00
GERN cash_flow (annual, 2024-12-31) — Depreciation: 1221000.00
GERN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1221000.00
GERN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1221000.00
GERN income_statement (annual, 2024-12-31) — Diluted Average Shares: 646033247.00
GERN income_statement (annual, 2024-12-31) — Diluted EPS: -0.27
GERN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -174572000.00
GERN income_statement (annual, 2024-12-31) — EBIT: -156068000.00
GERN income_statement (annual, 2024-12-31) — EBITDA: -154847000.00
GERN cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -12000.00
GERN cash_flow (annual, 2024-12-31) — End Cash Position: 80876000.00
GERN cash_flow (annual, 2024-12-31) — Financing Cash Flow: 334372000.00
GERN balance_sheet (annual, 2024-12-31) — Finished Goods: 3717000.00
GERN cash_flow (annual, 2024-12-31) — Free Cash Flow: -219298000.00
GERN balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 261000.00
GERN income_statement (annual, 2024-12-31) — General And Administrative Expense: 145732000.00
GERN income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 43371000.00
GERN balance_sheet (annual, 2024-12-31) — Gross PPE: 5888000.00
GERN income_statement (annual, 2024-12-31) — Gross Profit: 75738000.00
GERN balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 94519000.00
GERN balance_sheet (quarterly, 2024-12-31) — Held To Maturity Securities: 94519000.00
GERN income_statement (annual, 2024-12-31) — Interest Expense: 18504000.00
GERN income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 18504000.00
GERN income_statement (annual, 2024-12-31) — Interest Income: 19607000.00
GERN income_statement (annual, 2024-12-31) — Interest Income Non Operating: 19607000.00
GERN balance_sheet (annual, 2024-12-31) — Interest Payable: 2186000.00
GERN balance_sheet (annual, 2024-12-31) — Inventory: 38714000.00
GERN balance_sheet (annual, 2024-12-31) — Invested Capital: 398796000.00
GERN cash_flow (annual, 2024-12-31) — Investing Cash Flow: -106004000.00
GERN balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 94519000.00
GERN balance_sheet (annual, 2024-12-31) — Investments And Advances: 94519000.00
GERN cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 140729000.00
GERN cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
GERN cash_flow (annual, 2024-12-31) — Issuance Of Debt: 121120000.00
GERN balance_sheet (annual, 2024-12-31) — Leases: 129000.00
GERN balance_sheet (quarterly, 2024-12-31) — Leases: 129000.00
GERN balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 2266000.00
GERN balance_sheet (annual, 2024-12-31) — Long Term Debt: 118476000.00
GERN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 120742000.00
GERN cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 121120000.00
GERN cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -86554000.00
GERN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 2878000.00
GERN balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 2878000.00
GERN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 140729000.00
GERN cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
GERN balance_sheet (annual, 2024-12-31) — Net Debt: 39460000.00
GERN income_statement (annual, 2024-12-31) — Net Income: -174572000.00
GERN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -174572000.00
GERN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -174572000.00
GERN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -174572000.00
GERN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -174572000.00
GERN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -174572000.00
GERN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -174572000.00
GERN income_statement (annual, 2024-12-31) — Net Interest Income: 1103000.00
GERN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -105324000.00
GERN cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 34566000.00
GERN cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 34566000.00
GERN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1103000.00
GERN cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 125000000.00
GERN balance_sheet (annual, 2024-12-31) — Net PPE: 4191000.00
GERN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -680000.00
GERN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 280320000.00
GERN income_statement (annual, 2024-12-31) — Normalized EBITDA: -153140000.00
GERN income_statement (annual, 2024-12-31) — Normalized Income: -172870121.00
GERN cash_flow (annual, 2024-12-31) — Operating Cash Flow: -218618000.00
GERN cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1707000.00
GERN income_statement (annual, 2024-12-31) — Operating Income: -173732000.00
GERN income_statement (annual, 2024-12-31) — Operating Revenue: 89917000.00
GERN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 606387666.00
GERN balance_sheet (annual, 2024-12-31) — Other Current Assets: 5053000.00
GERN balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 20372000.00
GERN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 261000.00
GERN income_statement (annual, 2024-12-31) — Other Gand A: 145732000.00
GERN income_statement (quarterly, 2024-12-31) — Other Gand A: 43371000.00
GERN income_statement (annual, 2024-12-31) — Other Income Expense: -1943000.00
GERN cash_flow (annual, 2024-12-31) — Other Non Cash Items: 2237000.00
GERN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 4079000.00
GERN balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 104421000.00
GERN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -236000.00
GERN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 327550000.00
GERN income_statement (annual, 2024-12-31) — Other Special Charges: 1707000.00
GERN balance_sheet (annual, 2024-12-31) — Payables: 8595000.00
GERN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 43106000.00
GERN cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: 5345000.00
GERN balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 22808000.00
GERN balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
GERN balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
GERN income_statement (annual, 2024-12-31) — Pretax Income: -174572000.00
GERN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 34077000.00
GERN balance_sheet (annual, 2024-12-31) — Properties: 0.00
GERN balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
GERN cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: -251000.00
GERN cash_flow (annual, 2024-12-31) — Purchase Of Investment: -476932000.00
GERN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -680000.00
GERN cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 141000.00
GERN balance_sheet (annual, 2024-12-31) — Raw Materials: 4904000.00
GERN balance_sheet (annual, 2024-12-31) — Receivables: 38799000.00
GERN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1256000.00
GERN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1221000.00
GERN cash_flow (annual, 2024-12-31) — Repayment Of Debt: -86554000.00
GERN income_statement (annual, 2024-12-31) — Research And Development: 103738000.00
GERN balance_sheet (annual, 2024-12-31) — Restricted Cash: 1860000.00
GERN income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
GERN balance_sheet (annual, 2024-12-31) — Retained Earnings: -1772341000.00
GERN cash_flow (annual, 2024-12-31) — Sale Of Investment: 371608000.00
GERN income_statement (annual, 2024-12-31) — Selling General And Administration: 145732000.00
GERN balance_sheet (annual, 2024-12-31) — Share Issued: 606387666.00
GERN income_statement (annual, 2024-12-31) — Special Income Charges: -1707000.00
GERN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 31320000.00
GERN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 280320000.00
GERN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 280320000.00
GERN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -5121.00
GERN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
GERN balance_sheet (annual, 2024-12-31) — Total Assets: 593781000.00
GERN balance_sheet (annual, 2024-12-31) — Total Capitalization: 398796000.00
GERN balance_sheet (annual, 2024-12-31) — Total Debt: 121716000.00
GERN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 280320000.00
GERN income_statement (annual, 2024-12-31) — Total Expenses: 250726000.00
GERN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 313461000.00
GERN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 102789000.00
GERN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 225163000.00
GERN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -173732000.00
GERN income_statement (annual, 2024-12-31) — Total Unusual Items: -1707000.00
GERN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1707000.00
GERN balance_sheet (annual, 2024-12-31) — Work In Process: 30093000.00
GERN balance_sheet (annual, 2024-12-31) — Working Capital: 402694000.00
GERN income_statement (quarterly, 2025-03-31) — +Operating Expense: 55101000.00
GERN income_statement (quarterly, 2025-03-31) — +Total Revenue: 39603000.00
GERN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 8032000.00
GERN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 31166000.00
GERN balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 2817000.00
GERN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2059473000.00
GERN cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -2210000.00
GERN balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 58795000.00
GERN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 665905469.00
GERN income_statement (quarterly, 2025-03-31) — Basic EPS: -0.03
GERN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 80876000.00
GERN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 3050000.00
GERN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 637000.00
GERN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 83745000.00
GERN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 396877000.00
GERN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 256000.00
GERN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 52439000.00
GERN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -47979000.00
GERN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -563000.00
GERN cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -6663000.00
GERN cash_flow (quarterly, 2025-03-31) — Change In Inventory: -17508000.00
GERN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -191000.00
GERN cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -13204000.00
GERN cash_flow (quarterly, 2025-03-31) — Change In Payable: -563000.00
GERN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -7226000.00
GERN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -1688000.00
GERN cash_flow (quarterly, 2025-03-31) — Change In Receivables: 4649000.00
GERN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -35168000.00
GERN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 4649000.00
GERN cash_flow (quarterly, 2025-03-31) — Changes In Cash: 4716000.00
GERN balance_sheet (quarterly, 2025-03-31) — Common Stock: 637000.00
GERN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 268238000.00
GERN cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
GERN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1206000.00
GERN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 28005000.00
GERN balance_sheet (quarterly, 2025-03-31) — Current Assets: 495769000.00
GERN balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 981000.00
GERN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 981000.00
GERN balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 881000.00
GERN balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 881000.00
GERN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 63034000.00
GERN cash_flow (quarterly, 2025-03-31) — Depreciation: 308000.00
GERN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 308000.00
GERN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 308000.00
GERN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 665905469.00
GERN income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.03
GERN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -19835000.00
GERN income_statement (quarterly, 2025-03-31) — EBIT: -11635000.00
GERN income_statement (quarterly, 2025-03-31) — EBITDA: -11327000.00
GERN cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 18000.00
GERN cash_flow (quarterly, 2025-03-31) — End Cash Position: 85610000.00
GERN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 256000.00
GERN balance_sheet (quarterly, 2025-03-31) — Finished Goods: 7417000.00
GERN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -47979000.00
GERN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 304000.00
GERN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 40023000.00
GERN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3851000.00
GERN income_statement (quarterly, 2025-03-31) — Gross Profit: 38397000.00
GERN income_statement (quarterly, 2025-03-31) — Interest Expense: 8200000.00
GERN income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 8200000.00
GERN income_statement (quarterly, 2025-03-31) — Interest Income: 5152000.00
GERN income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 5152000.00
GERN balance_sheet (quarterly, 2025-03-31) — Interest Payable: 0.00
GERN balance_sheet (quarterly, 2025-03-31) — Inventory: 56222000.00
GERN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 386966000.00
GERN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 52439000.00
GERN balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 58795000.00
GERN balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 58795000.00
GERN cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
GERN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2069000.00
GERN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 118728000.00
GERN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 120797000.00
GERN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
GERN balance_sheet (quarterly, 2025-03-31) — Net Debt: 34983000.00
GERN income_statement (quarterly, 2025-03-31) — Net Income: -19835000.00
GERN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -19835000.00
GERN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -19835000.00
GERN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -19835000.00
GERN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -19835000.00
GERN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -19835000.00
GERN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -19835000.00
GERN income_statement (quarterly, 2025-03-31) — Net Interest Income: -3048000.00
GERN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 52407000.00
GERN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -3048000.00
GERN balance_sheet (quarterly, 2025-03-31) — Net PPE: 3851000.00
GERN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 32000.00
GERN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 268238000.00
GERN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -11327000.00
GERN income_statement (quarterly, 2025-03-31) — Normalized Income: -19835000.00
GERN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -47979000.00
GERN income_statement (quarterly, 2025-03-31) — Operating Income: -16704000.00
GERN income_statement (quarterly, 2025-03-31) — Operating Revenue: 45479000.00
GERN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 636917758.00
GERN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 6822000.00
GERN balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 15532000.00
GERN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 304000.00
GERN income_statement (quarterly, 2025-03-31) — Other Gand A: 40023000.00
GERN income_statement (quarterly, 2025-03-31) — Other Income Expense: -83000.00
GERN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1372000.00
GERN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 4035000.00
GERN balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 110381000.00
GERN income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -83000.00
GERN balance_sheet (quarterly, 2025-03-31) — Other Properties: 3851000.00
GERN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 313132000.00
GERN balance_sheet (quarterly, 2025-03-31) — Payables: 8032000.00
GERN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 36037000.00
GERN balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 9603000.00
GERN income_statement (quarterly, 2025-03-31) — Pretax Income: -19835000.00
GERN cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 256000.00
GERN cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 131000.00
GERN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -46477000.00
GERN balance_sheet (quarterly, 2025-03-31) — Raw Materials: 7383000.00
GERN balance_sheet (quarterly, 2025-03-31) — Receivables: 33983000.00
GERN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1206000.00
GERN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 308000.00
GERN income_statement (quarterly, 2025-03-31) — Research And Development: 15078000.00
GERN balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1865000.00
GERN income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
GERN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1792176000.00
GERN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 98884000.00
GERN cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 32000.00
GERN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 40023000.00
GERN balance_sheet (quarterly, 2025-03-31) — Share Issued: 636917758.00
GERN income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
GERN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 7423000.00
GERN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 268238000.00
GERN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 268238000.00
GERN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
GERN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
GERN balance_sheet (quarterly, 2025-03-31) — Total Assets: 562450000.00
GERN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 386966000.00
GERN balance_sheet (quarterly, 2025-03-31) — Total Debt: 121778000.00
GERN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 268238000.00
GERN income_statement (quarterly, 2025-03-31) — Total Expenses: 56307000.00
GERN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 294212000.00
GERN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 66681000.00
GERN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 231178000.00
GERN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -16704000.00
GERN income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
GERN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GERN balance_sheet (quarterly, 2025-03-31) — Work In Process: 41422000.00
GERN balance_sheet (quarterly, 2025-03-31) — Working Capital: 432735000.00
GERN income_statement (quarterly, 2025-06-30) — +Operating Expense: 60300000.00
GERN income_statement (quarterly, 2025-06-30) — +Total Revenue: 49036000.00
GERN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 8226000.00
GERN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 36608000.00
GERN balance_sheet (quarterly, 2025-06-30) — Accrued Interest Receivable: 2755000.00
GERN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 2067327000.00
GERN cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -1738000.00
GERN balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 42743000.00
GERN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 666170358.00
GERN income_statement (quarterly, 2025-06-30) — Basic EPS: -0.02
GERN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 85610000.00
GERN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2852000.00
GERN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 638000.00
GERN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 77734000.00
GERN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 387981000.00
GERN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1091000.00
GERN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 20315000.00
GERN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -27415000.00
GERN cash_flow (quarterly, 2025-06-30) — Change In Inventory: -12902000.00
GERN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -21293000.00
GERN cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 515000.00
GERN cash_flow (quarterly, 2025-06-30) — Change In Receivables: -5333000.00
GERN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -18583000.00
GERN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -5333000.00
GERN cash_flow (quarterly, 2025-06-30) — Changes In Cash: -6009000.00
GERN balance_sheet (quarterly, 2025-06-30) — Common Stock: 638000.00
GERN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 259531000.00
GERN cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
GERN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1190000.00
GERN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 26294000.00
GERN balance_sheet (quarterly, 2025-06-30) — Current Assets: 505595000.00
GERN balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 987000.00
GERN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 987000.00
GERN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 64283000.00
GERN cash_flow (quarterly, 2025-06-30) — Depreciation: 309000.00
GERN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 309000.00
GERN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 309000.00
GERN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 666170358.00
GERN income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.02
GERN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -16375000.00
GERN income_statement (quarterly, 2025-06-30) — EBIT: -7859000.00
GERN income_statement (quarterly, 2025-06-30) — EBITDA: -7550000.00
GERN cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 3000.00
GERN cash_flow (quarterly, 2025-06-30) — End Cash Position: 79604000.00
GERN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1091000.00
GERN balance_sheet (quarterly, 2025-06-30) — Finished Goods: 14532000.00
GERN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -27553000.00
GERN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 117000.00
GERN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 3712000.00
GERN income_statement (quarterly, 2025-06-30) — Gross Profit: 47846000.00
GERN income_statement (quarterly, 2025-06-30) — Interest Expense: 8516000.00
GERN income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 8516000.00
GERN income_statement (quarterly, 2025-06-30) — Interest Income: 4656000.00
GERN income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 4656000.00
GERN balance_sheet (quarterly, 2025-06-30) — Interest Payable: 0.00
GERN balance_sheet (quarterly, 2025-06-30) — Inventory: 69125000.00
GERN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 378522000.00
GERN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 20315000.00
GERN balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 42743000.00
GERN balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 42743000.00
GERN cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
GERN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1865000.00
GERN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 118991000.00
GERN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 120856000.00
GERN cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
GERN balance_sheet (quarterly, 2025-06-30) — Net Debt: 41257000.00
GERN income_statement (quarterly, 2025-06-30) — Net Income: -16375000.00
GERN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -16375000.00
GERN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -16375000.00
GERN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -16375000.00
GERN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -16375000.00
GERN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -16375000.00
GERN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -16375000.00
GERN income_statement (quarterly, 2025-06-30) — Net Interest Income: -3860000.00
GERN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 20485000.00
GERN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -3860000.00
GERN balance_sheet (quarterly, 2025-06-30) — Net PPE: 3712000.00
GERN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -170000.00
GERN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 259531000.00
GERN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -7550000.00
GERN income_statement (quarterly, 2025-06-30) — Normalized Income: -16375000.00
GERN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -27415000.00
GERN income_statement (quarterly, 2025-06-30) — Operating Income: -12454000.00
GERN income_statement (quarterly, 2025-06-30) — Operating Revenue: 57903000.00
GERN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 637849739.00
GERN balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 7256000.00
GERN balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 17440000.00
GERN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 117000.00
GERN income_statement (quarterly, 2025-06-30) — Other Income Expense: -61000.00
GERN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2318000.00
GERN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 3148000.00
GERN balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 110528000.00
GERN income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -61000.00
GERN balance_sheet (quarterly, 2025-06-30) — Other Properties: 3712000.00
GERN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 310247000.00
GERN balance_sheet (quarterly, 2025-06-30) — Payables: 8226000.00
GERN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 34520000.00
GERN balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 11336000.00
GERN income_statement (quarterly, 2025-06-30) — Pretax Income: -16375000.00
GERN cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 1091000.00
GERN cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: -110000.00
GERN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -76696000.00
GERN balance_sheet (quarterly, 2025-06-30) — Raw Materials: 7581000.00
GERN balance_sheet (quarterly, 2025-06-30) — Receivables: 39363000.00
GERN income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1190000.00
GERN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 309000.00
GERN income_statement (quarterly, 2025-06-30) — Research And Development: 21736000.00
GERN balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 1870000.00
GERN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1808551000.00
GERN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 97181000.00
GERN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 38564000.00
GERN balance_sheet (quarterly, 2025-06-30) — Share Issued: 637849739.00
GERN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 6764000.00
GERN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 259531000.00
GERN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 259531000.00
GERN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
GERN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
GERN balance_sheet (quarterly, 2025-06-30) — Total Assets: 555198000.00
GERN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 378522000.00
GERN balance_sheet (quarterly, 2025-06-30) — Total Debt: 121843000.00
GERN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 259531000.00
GERN income_statement (quarterly, 2025-06-30) — Total Expenses: 61490000.00
GERN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 295667000.00
GERN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 49603000.00
GERN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 231384000.00
GERN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -12454000.00
GERN balance_sheet (quarterly, 2025-06-30) — Work In Process: 47012000.00
GERN balance_sheet (quarterly, 2025-06-30) — Working Capital: 441312000.00
GERN income_statement (quarterly, 2025-09-30) — +Operating Expense: 60071000.00
GERN income_statement (quarterly, 2025-09-30) — +Total Revenue: 47227000.00
GERN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 11111000.00
GERN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 35361000.00
GERN balance_sheet (quarterly, 2025-09-30) — Accrued Interest Receivable: 2295000.00
GERN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 2074640000.00
GERN cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -1529000.00
GERN balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 39063000.00
GERN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 667101756.00
GERN income_statement (quarterly, 2025-09-30) — Basic EPS: -0.03
GERN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 79604000.00
GERN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2652000.00
GERN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 638000.00
GERN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 78117000.00
GERN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 380532000.00
GERN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 542000.00
GERN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 13348000.00
GERN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -13576000.00
GERN cash_flow (quarterly, 2025-09-30) — Change In Inventory: -26298000.00
GERN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 21370000.00
GERN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 1340000.00
GERN cash_flow (quarterly, 2025-09-30) — Change In Receivables: 1273000.00
GERN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -2315000.00
GERN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 1273000.00
GERN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 314000.00
GERN balance_sheet (quarterly, 2025-09-30) — Common Stock: 638000.00
GERN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 248707000.00
GERN cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
GERN income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1043000.00
GERN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 39928000.00
GERN balance_sheet (quarterly, 2025-09-30) — Current Assets: 522342000.00
GERN balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 994000.00
GERN balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 994000.00
GERN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 87712000.00
GERN cash_flow (quarterly, 2025-09-30) — Depreciation: 312000.00
GERN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 312000.00
GERN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 312000.00
GERN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 667101756.00
GERN income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.03
GERN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -18428000.00
GERN income_statement (quarterly, 2025-09-30) — EBIT: -9784000.00
GERN income_statement (quarterly, 2025-09-30) — EBITDA: -9472000.00
GERN cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 75000.00
GERN cash_flow (quarterly, 2025-09-30) — End Cash Position: 79993000.00
GERN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 542000.00
GERN balance_sheet (quarterly, 2025-09-30) — Finished Goods: 18407000.00
GERN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -13487000.00
GERN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 408000.00
GERN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3312000.00
GERN income_statement (quarterly, 2025-09-30) — Gross Profit: 46184000.00
GERN income_statement (quarterly, 2025-09-30) — Interest Expense: 8644000.00
GERN income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 8644000.00
GERN income_statement (quarterly, 2025-09-30) — Interest Income: 4264000.00
GERN income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 4264000.00
GERN balance_sheet (quarterly, 2025-09-30) — Interest Payable: 0.00
GERN balance_sheet (quarterly, 2025-09-30) — Inventory: 95422000.00
GERN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 367971000.00
GERN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 13348000.00
GERN balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 39063000.00
GERN balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 39063000.00
GERN cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
GERN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1658000.00
GERN balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 119264000.00
GERN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 120922000.00
GERN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
GERN balance_sheet (quarterly, 2025-09-30) — Net Debt: 41147000.00
GERN income_statement (quarterly, 2025-09-30) — Net Income: -18428000.00
GERN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -18428000.00
GERN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -18428000.00
GERN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -18428000.00
GERN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -18428000.00
GERN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -18428000.00
GERN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -18428000.00
GERN income_statement (quarterly, 2025-09-30) — Net Interest Income: -4380000.00
GERN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 13259000.00
GERN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -4380000.00
GERN balance_sheet (quarterly, 2025-09-30) — Net PPE: 3312000.00
GERN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 89000.00
GERN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 248707000.00
GERN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -9472000.00
GERN income_statement (quarterly, 2025-09-30) — Normalized Income: -18428000.00
GERN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -13576000.00
GERN income_statement (quarterly, 2025-09-30) — Operating Income: -13887000.00
GERN income_statement (quarterly, 2025-09-30) — Operating Revenue: 60248000.00
GERN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 638355275.00
GERN balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 6856000.00
GERN balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 19291000.00
GERN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 408000.00
GERN income_statement (quarterly, 2025-09-30) — Other Income Expense: -161000.00
GERN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1638000.00
GERN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2665000.00
GERN balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 110041000.00
GERN income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -161000.00
GERN balance_sheet (quarterly, 2025-09-30) — Other Properties: 3312000.00
GERN balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 302415000.00
GERN balance_sheet (quarterly, 2025-09-30) — Payables: 11111000.00
GERN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 51039000.00
GERN balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 16388000.00
GERN income_statement (quarterly, 2025-09-30) — Pretax Income: -18428000.00
GERN cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 542000.00
GERN cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: -25000.00
GERN cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -77029000.00
GERN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 89000.00
GERN balance_sheet (quarterly, 2025-09-30) — Raw Materials: 13863000.00